Archives of 2015

Melanoma treatment and RWD

23.11.2015 – Melinda Manley Daumont presented a poster of a study conducted by EPID Research “Comparative effectiveness research of treatments for advanced melanoma in Europe using existing real-world data sources: A feasibility assessment” in the Society for Melanoma Research 2015 International Congress, 18-21 November 2015 – Poster – Abstract

Risk of stroke with warfarin therapy

17.11.2015 – Mika Lehto gave an oral presentation of a study conducted by EPID Research titled “Risk of stroke, bleeding events and mortality is strongly associated with the quality of warfarin therapy. Results from the FinWAF registry with 54,568 patients” in the American Heart Association’s Scientific Session 2015, 12-16 November 2015. For further information, please see the […]

Poor quality of Warfarin Therapy

17.11.2015 – Pekka Raatikainen presented a poster of a study conducted by EPID Research “Poor Quality of Warfarin Therapy is Associated With Elevated Risk Of Myocardial Infarction in Patients With Atrial Fibrillation. Results From the FinWAF Registry With 54568 Patients” in the American Heart Association’s Scientific Session 2015, 12-16 November 2015 – Abstract

Children’s medication in the Nordic countries

12.11.2015 – Disa Långström presented the results of her Master’s Thesis supervised by EPID Research as poster “Children’s medication in the Nordic countries – Survey on national administrative register data” in the ISPOR 18th Annual European Congress, 7-11 November 2015 – Poster

Treatment of type 2 diabetic patients

23.10.2015 – Our study, A retrospective nationwide cohort study to investigate the treatment of type 2 diabetic patients in Finland – DAHLIA, is now registered under the ENCePP Seal. The purpose of this study is to describe type 2 diabetes mellitus patients in Finland, especially their antidiabetic medication use and to discuss the progression of the disease […]

The risk of severe hypoglycaemia and use of certain antidiabetic drugs

18.9.2015 – A study on the risk of severe hypoglycaemia and use of certain antidiabetic drugs was presented in the 51st European Association for the Study of Diabetes Annual Meeting in Stockholm, Sweden (September 14-18, 2015). Oral presentation titled “The risk of severe hypoglycaemia events in working-age adults and use of basal insulins NPH, glargine […]

Research Director Dr. Pasi Korhonen’s presentation

28.8.2015 – Our Research Director Dr. Pasi Korhonen gave an oral presentation titled “Preliminary Results of Bladder Cancer Risk in Relation To Exposure To Pioglitazone Among Patients With T2DM in the Pan European Multi-Database Bladder Cancer Risk Characterisation Study” in the 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management in Boston, US on August 24, 2015. For […]

Multi-Database Bladder Cancer Risk Characterisation Study

8.6.2015 – Results of the Pan European Multi-Database Bladder Cancer Risk Characterisation Study were presented at American Diabetes Association’s 75th Scientific Session – for further information, please see press release – Poster

EPID Research’s study of painkillers and tranquillizing benzodiazepines

1.6.2015 – A recent collaborative study in which EPID Research participated found that the use of painkillers and tranquillizing benzodiazepines was associated with an increased risk of committing a homicide, while use of anti-depressants was linked only to a slightly elevated risk. More detailed information of this study can be found in University of Eastern […]

The risk of fatal stroke in Finnish postmenopausal hormone therapy users

16.4.2015 – A retrospective nationwide register study finds that the change in prescribing policy after the Women’s Health Initiative study did not affect the risk of fatal stroke in Finnish postmenopausal hormone therapy users. The risk of fatal stroke in Finnish postmenopausal hormone therapy users before and after the Women’s Health Initiative: A cohort study. Published in Maturitas […]
  • 1
  • 2